ASTEC lymphadenectomy and radiation therapy studies: Are conclusions valid?

Gynecologic Oncology

Volumn 116, Issue 3, 2010, Pages 293-294

  Creasman, W T ^a   Mutch, David E ^b   Herzog, Thomas J ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL HYSTERECTOMY; ADVANCED CANCER; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE INTERVAL; EARLY CANCER; EDITORIAL; EMERGENCY HEALTH SERVICE; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MYOMETRIUM; PELVIS LYMPHADENECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RISK FACTOR; SALPINGOOOPHORECTOMY; TREATMENT INDICATION; TREATMENT OUTCOME; VALIDATION PROCESS;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; OVARIECTOMY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 75749118203     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.10.065     Document Type: Editorial

References (2)

1. ASTEC study group, Kitchener H., Swart A.M., Qian Q., Amos C., and Parmer M.K. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373 9658 (2009) 125-136
2. STEC/En.5 Study Group, Blake P., Swart A.M., Orton J., Kitchener H., Whelan T., Lukka H., Eisenhauer E., and Bacon M. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG En.5 randomized trials): pooled trial results, systematic review, and metastatic-analysis. Lancet 373 9658 (2009) 137-146